Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Cash flows from operating activities:
Net income including noncontrolling interests	$ 158,756	$ 407,368
Adjustments to reconcile net income to net cash from operating activities:
Depreciation and amortization	80,182	75,568
Impairment and related charges	130,411	0
Share-based compensation expense related to equity classified awards	43,141	50,465
Non-cash restructuring and other related charges	6,126	14,026
Amortization and write-off of program rights	622,204	696,326
Amortization of deferred carriage fees	21,088	14,624
Unrealized foreign currency transaction loss	9,242	489
Amortization of deferred financing costs and discounts on indebtedness	6,039	5,970
Loss on extinguishment of debt	2,908	0
Bad debt expense	340	3,628
Deferred income taxes	12,403	(65,245)
Write-down of non-marketable equity securities and note receivable	5,103	20,206
Other, net	(10,696)	(8,481)
Changes in assets and liabilities:
Accounts receivable, trade (including amounts due from related parties, net)	92,328	6,993
Prepaid expenses and other assets	79,098	(121,375)
Program rights and obligations, net	(565,267)	(676,718)
Income taxes payable	17,265	3,101
Deferred revenue	(2,234)	10,395
Deferred carriage fees, net	(15,057)	(14,409)
Accounts payable, accrued liabilities and other liabilities	(49,293)	(22,534)
Net cash provided by operating activities	644,087	400,397
Cash flows from investing activities:
Capital expenditures	(34,990)	(69,096)
Return of capital from investees	924	9,232
Acquisition of investment securities	(4,111)	0
Principal payment received on loan to investee	3,750	0
Proceeds from sale of investments	10,000	0
Net cash used in investing activities	(24,427)	(59,864)
Cash flows from financing activities:
Proceeds from the issuance of long-term debt	6,000	1,521
Principal payments on long-term debt	(242,500)	(12,613)
Deemed repurchases of restricted stock units	(8,947)	(23,019)
Purchase of treasury stock	(102,938)	(70,598)
Proceeds from stock option exercises	0	4,630
Principal payments on finance lease obligations	(2,404)	(4,059)
Distributions to noncontrolling interests	(13,955)	(13,545)
Net cash used in financing activities	(364,744)	(117,683)
Net increase in cash and cash equivalents	254,916	222,850
Effect of exchange rate changes on cash and cash equivalents	774	(4,350)
Cash and cash equivalents at beginning of period	816,170	554,886
Cash and cash equivalents at end of period	$ 1,071,860	$ 773,386